Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy

Read full text Summarise with VIRAT
Authors: Jasmine Pipella, Peter J. Thompson
Cited by: 0
References: 106

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pharmacologic interventions for type 1 diabetes (T1D) have advanced significantly in recent years with the advent of the first FDA approved therapy teplizumab for delaying symptomatic disease onset in 2022. Despite this progress, major hurdles remain in moving toward personalized medicine approaches for T1D. Here, we highlight the examples of heterogeneity in therapeutic responses to recent beta cell and immune interventions and what these studies can teach us about how to tailor therapy for maximizing benefit to patients at risk of or living with T1D. We examine the differences between proposed endotypes, such as childhood-onset versus adult-onset disease, and how these distinctions may inform the use of different therapies. We also explore the importance of disease staging in determining therapeutic windows, as early interventions appear most effective before extensive beta cell loss. Emerging biomarkers including autoantibody profiles, metabolic indices, and circulating nucleic acids offer additional tools for stratifying patients and predicting responses. Ultimately, recognizing and leveraging patient heterogeneity provides an opportunity to align therapies with underlying physiology, moving beyond 'one-size-fits all' approaches. The promise of personalized T1D therapy will be realized by surmounting the barriers to implementation, including trial design, paediatric underrepresentation, and cost.

Fields of Study & Subjects

Diabetes and associated disorders Diabetes Management and Research T-cell and B-cell Immunology

Publication details

Journal / source
Diabetes Obesity and Metabolism
Volume
28
Issue
6
Pages
4529–4545
Publication date
30 March 2026
Language
EN